remimazolam
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract Background: Remimazolam is a newly developed benzodiazepine as an alternative of conventional sedatives in the procedure…
Remimazolam is an ultrashort-acting benzodiazepine proposed for sedation in gastrointestinal endoscopy. To assess its safety and…
A new water‐soluble benzodiazepine derivative, CNS 7056 (named as remimazolam), has been undergoing many reactions in recent…
Monitored anesthesia care is the application of varying degrees of sedation and analgesia for a patient undergoing a diagnostic…
Purpose of review Many studies of new intravenous sedative drugs have been published last year, including several phase I trials…
Remimazolam is a new ultra-short-acting and water-soluble benzodiazepine derivative,which produces sedation with rapid onset and…
A-3309, Abobotulinumtoxin A, Adalimumab, AIDSVAX gp120 B/E, ALVAC E120TMG, Atorvastatin calcium; Bepridil, Bevacizumab…